Invesco Dorsey Wright Healthcare Momentum ETF (PTH US)
PTH US$61.82
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Share price activity
- Last (Price)
- 61.82
- Change
- ▲ 1.60 (2.66)
- Bid / Ask
- 53.07 - 69.83
- Volume
- 6,121
- Turnover
- 334,164
- Open
- 60.24
- Day Range
- 60.24 - 61.82
- VWAP
- 61.55
- Prev Close
- 60.22
- Last Trade
- 28/10 3:59pm
Fund profile
Fund size
$285.5M
OCT 2026
Distributions
Quarterly
Since inception
20.0 yrs
OCT 2006
- Legal name
- Invesco Dorsey Wright Healthcare Momentum ETF
- Issuer
- Invesco
- Type
- Exchange-Traded Fund
- Structure
- Open Ended Investment Company
- Management style
- Index fund
- Morningstar category
- Health
- Category index
- Morningstar US Health TR USD
- Benchmark
- NASDAQ Composite TR USD
- ETF net assets
- $285.5M
- Units on issue
- 4.9M
- Management fee
- 0.50% p.a.
- Domicile
- United States
- Base currency
- USD
- Inception
- 12 OCT 2006
- Listed
- 7 DEC 2016
- Index provider
- NASDAQ Index
Objective and strategy
The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright® Healthcare Technical Leaders Index (the "underlying index"). The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics. Under normal circumstances, at least 80% of the value of its net assets, plus the amount of any borrowings for investment purposes, in the components of the underlying index and in derivatives and other investments that have economic characteristics similar to the components of the underlying index.
Asset allocation
US equity 95.02%Non-US equity 4.86%
| Asset class | Net % | Long % | Short % |
|---|---|---|---|
| Equity | 99.88 | 99.88 | — |
| Bond | 0.00 | 0.00 | — |
| Cash | 0.12 | 0.12 | — |
| Other | 0.00 | 0.00 | — |
Sector exposure
Cyclical 0.00%Sensitive 0.00%Defensive 100.00%
- Basic Materials
- 0.00%
- Consumer Cyclical
- 0.00%
- Financial Services
- 0.00%
- Real Estate
- 0.00%
- Communication Services
- 0.00%
- Energy
- 0.00%
- Industrials
- 0.00%
- Technology
- 0.00%
- Consumer Defensive
- 0.00%
- Healthcare
- 100.00%
- Utilities
- 0.00%
Region exposure
Developed markets 100.00%Emerging markets 0.00%
- North America
- 95.13%
- Latin America
- 0.00%
- United Kingdom
- 3.83%
- Europe Developed
- 1.04%
- Europe Emerging
- 0.00%
- Africa / Middle East
- 0.00%
- Japan
- 0.00%
- Australasia
- 0.00%
- Asia Developed
- 0.00%
- Asia Emerging
- 0.00%
Country exposure
- United States
- 95.13%
- United Kingdom
- 3.83%
- Netherlands
- 1.04%
Style box
- Style
- Small Growth
Size score
57
Value-growth score
270
Economic moat
Wide 0%Narrow 60%None 40%
Market capitalisation
- Giant
- 0.00%
- Large
- 3.83%
- Mid
- 23.56%
- Small
- 45.24%
- Micro
- 27.36%
Large 4%Mid 24%Small 45%Micro 27%
- Average market cap
- $8.04B
- Number of holdings
- 55
- Shares held
- 52
Portfolio statistics · 23 OCT 2026
- Price / book
- 7.46
- Price / sales
- 4.18
- Price / cash flow
- 14.87
- Dividend yield
- 0.01%
- Assets in top 10
- 36.14%
- Return on equity
- -5.20%
- Net margin
- -10.02%
Top holdings · top 10 = 41.06% of assets
| Holding | % Weight | First bought | Market value | Currency | Units held | Sector | Country | |
|---|---|---|---|---|---|---|---|---|
| Moderna Inc MRNA | 6.35 | APR 2026 | 23.3M | USD | 121,202 | Healthcare | United States | |
| Guardant Health Inc GH | 5.23 | JUL 2026 | 19.2M | USD | 107,669 | Healthcare | United States | |
| Revolution Medicines Inc Ordinary Shares RVMD | 5.16 | JUL 2026 | 18.9M | USD | 92,269 | Healthcare | United States | |
| Roivant Sciences Ltd Ordinary Shares ROIV | 5.09 | JAN 2026 | 18.7M | USD | 511,087 | Healthcare | United Kingdom | |
| 10x Genomics Inc Ordinary Shares - Class A TXG | 4.14 | JUL 2026 | 15.2M | USD | 168,328 | Healthcare | United States | |
| BrightSpring Health Services Inc BTSG | 3.65 | JUL 2025 | 13.4M | USD | 236,307 | Healthcare | United States | |
| Axsome Therapeutics Inc AXSM | 3.33 | JAN 2026 | 12.2M | USD | 66,274 | Healthcare | United States | |
| Twist Bioscience Corp TWST | 3.20 | APR 2026 | 11.8M | USD | 60,852 | Healthcare | United States | |
| Illumina Inc ILMN | 2.65 | JUL 2026 | 9.7M | USD | 35,537 | Healthcare | United States | |
| Erasca Inc ERAS | 2.26 | APR 2026 | 8.3M | USD | 567,358 | Healthcare | United States |
Trailing returns · 30 SEP 2026
Fund (NAV) Market price
1M
0.0
3M
1.8
6M
23.8
YTD
22.2
1Y
41.8
3Y
23.0
5Y
3.1
10Y
13.6
| Period | Fund (NAV) % | Market price % | Before fees % | Rank in category |
|---|---|---|---|---|
| 1 month | 0.02 | -0.06 | — | 24 / 176 |
| 3 months | 1.84 | 1.67 | — | 58 / 175 |
| 6 months | 23.77 | 24.00 | — | 27 / 171 |
| Year to date | 22.23 | 22.25 | — | 21 / 171 |
| 1 year | 41.76 | 41.99 | — | 24 / 170 |
| 3 years p.a. | 23.04 | 23.09 | — | 15 / 160 |
| 5 years p.a. | 3.12 | 3.13 | — | 71 / 153 |
| 10 years p.a. | 13.57 | 13.56 | — | 1 / 121 |
Returns to 30 SEP 2026, periods of 3 years and longer annualised. Rank is the percentile in the Morningstar category at 30 SEP 2026 (1 = best) over the funds ranked.
Calendar year returns
Total Capital
2016
-12.9
2017
50.1
2018
-0.9
2019
33.8
2020
67.1
2021
-3.0
2022
-20.7
2023
-4.4
2024
2.0
2025
28.1
| Year | Total % | Capital % | Rank in category |
|---|---|---|---|
| 2025 | 28.08 | 24.26 | 22 / 172 |
| 2024 | 2.05 | 1.98 | 48 / 176 |
| 2023 | -4.37 | -4.37 | 90 / 176 |
| 2022 | -20.67 | -20.67 | 73 / 176 |
| 2021 | -3.02 | -3.02 | 78 / 166 |
| 2020 | 67.14 | 67.14 | 2 / 157 |
| 2019 | 33.79 | 33.79 | 13 / 145 |
| 2018 | -0.86 | -0.86 | 62 / 140 |
| 2017 | 50.11 | 50.11 | 2 / 144 |
| 2016 | -12.91 | -12.91 | 68 / 134 |
| 2015 | 2.28 | 2.28 | 95 / 128 |
Risk statistics · 30 SEP 2026
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Alpha | 32.46 | 4.59 | -5.00 | 3.79 |
| Beta | 0.10 | 0.92 | 0.85 | 0.91 |
| R-squared | 0.39 | 19.91 | 28.00 | 30.80 |
| Standard deviation | 21.77 | 24.73 | 23.79 | 23.96 |
| Sharpe ratio | 1.55 | 0.78 | 0.08 | 0.55 |
| Sortino ratio | 4.44 | 1.43 | 0.12 | 0.88 |
| Tracking error | 25.24 | 22.15 | 20.25 | 20.01 |
| Information ratio | 0.99 | 0.06 | -0.42 | 0.06 |
| Upside capture % | 46.82 | 98.49 | 76.96 | 106.59 |
| Downside capture % | -256.87 | 82.42 | 110.25 | 104.41 |
| Maximum drawdown % | -8.19 | -25.28 | -45.94 | -45.94 |
Measured against MSCI ACWI NR USD with USTREAS T-Bill Auction Ave 3 Mon as the risk-free rate, to 30 SEP 2026. Maximum drawdown is on gross returns at the latest quarter end.
Portfolio risk score
Risk score
102.6
Morningstar Portfolio Risk Score at 30 SEP 2026.
- Tracking volatility
- 0.079
- Est. holding cost %
- 0.629
- Market impact cost %
- 0.013
- Best quarter
- 43.72% · JUN 2020
- Worst quarter
- -28.03% · FEB 2016
Fees and costs
- Management fees and costs
- 0.50% p.a.
- PDS dated
- 28 AUG 2026
Distributions
- Latest distribution
- 1.5265
- Ex Date
- 22 DEC 2025
- Record Date
- 22 DEC 2025
- Pay Date
- 26 DEC 2025
- NAV at ex date
- 50.74
Distributions by year
2024
1.5
2023
0.0
| Year | Per unit ($) |
|---|---|
| 2024 | 1.5265 |
| 2023 | 0.0255 |
Distribution history
| Ex Date | Per unit ($) |
|---|---|
| 22 DEC 2025 | 1.5265 |
| 24 JUN 2024 | 0.0255 |
| 20 DEC 2013 | 0.0114 |
| 20 SEP 2013 | 0.0026 |
| 21 JUN 2013 | 0.0368 |
| 21 DEC 2012 | 0.1090 |
| 15 JUN 2012 | 0.0084 |
| 18 DEC 2009 | 0.0194 |
| 19 JUN 2009 | 0.0084 |
Sustainability rating · 31 AUG 2026
Low
ESG risk score
28.94
Category average 21.96
- Rank in category
- 91st percentile of 594 funds
- Environmental risk
- 0.75
- Social risk
- 3.89
- Governance risk
- 1.37
- Portfolio covered
- 94.3%
ESG risk of holdings
- Negligible
- 0.00%
- Low
- 11.71%
- Medium
- 37.18%
- High
- 51.10%
- Severe
- 0.00%
0.00% of assets are in companies with high or severe controversies.
Carbon · 31 AUG 2026
Carbon risk score
3.08
Category average 2.74
- Carbon risk
- Low Risk
- Rank in category
- 30th percentile of 313 funds
- Fossil fuel involvement
- 0.00%
- Category average
- 0.16%
- Low Carbon Designation
- Yes
- Portfolio covered
- 94.3%
Fund managers
- Peter Hubbard
- Michael Jeanette
- Pratik Doshi
Tenure
- Number of managers
- 3
- Average tenure
- 14.6 years
- Longest tenure
- 19.3 years
- Longest serving
- Peter Hubbard · since 1 JUN 2007
- Most recent appointment
- Pratik Doshi · since 28 AUG 2020
- Managed since
- 1 JUN 2007
- Other funds managed
- 292
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.